Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

U.S. Healthcare Sector Analysis

UpdatedFeb 19, 2025
DataAggregated Company Financials
Companies1400
  • 7D-0.7%
  • 3M0.4%
  • 1Y-1.2%
  • YTD3.9%

Over the last 7 days, the Healthcare industry has remained flat, although notably CVS Health gained 19%. Furthermore, the industry has been flat for the past year as well. Looking forward, earnings are forecast to grow by 18% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 19 Feb 2025US$5.8tUS$2.6tUS$82.1b26.1x70.8x2.2x
Fri, 17 Jan 2025US$5.9tUS$2.9tUS$78.9b27.5x74.3x2x
Sun, 15 Dec 2024US$5.9tUS$2.9tUS$77.7b28.3x76x2x
Tue, 12 Nov 2024US$6.3tUS$2.9tUS$76.4b28.5x82.3x2.2x
Thu, 10 Oct 2024US$6.2tUS$2.8tUS$60.1b29.7x102.3x2.2x
Sat, 07 Sep 2024US$6.2tUS$2.8tUS$60.4b30.5x102.3x2.2x
Mon, 05 Aug 2024US$6.4tUS$2.9tUS$64.1b31x99.1x2.2x
Wed, 03 Jul 2024US$6.1tUS$2.8tUS$62.3b29.9x98.8x2.2x
Fri, 31 May 2024US$6.0tUS$2.8tUS$64.2b29.8x94.1x2.1x
Sun, 28 Apr 2024US$6.0tUS$2.8tUS$68.3b31.5x87.7x2.1x
Tue, 26 Mar 2024US$6.2tUS$2.8tUS$82.2b31.8x75.9x2.2x
Thu, 22 Feb 2024US$6.2tUS$2.8tUS$86.0b31.3x72.3x2.2x
Sat, 20 Jan 2024US$6.3tUS$2.8tUS$90.8b32.4x69.4x2.2x
Mon, 18 Dec 2023US$6.1tUS$2.8tUS$91.5b32.3x66.5x2.2x
Wed, 15 Nov 2023US$5.7tUS$2.8tUS$90.9b27.8x62.7x2x
Fri, 13 Oct 2023US$5.9tUS$2.8tUS$98.3b25.7x59.9x2.1x
Sun, 10 Sep 2023US$6.1tUS$2.8tUS$98.6b27.5x61.8x2.2x
Tue, 08 Aug 2023US$6.1tUS$2.8tUS$97.9b28.3x62.7x2.2x
Thu, 06 Jul 2023US$6.0tUS$2.7tUS$110.2b26x54.4x2.2x
Sat, 03 Jun 2023US$6.0tUS$2.7tUS$110.4b25.2x53.9x2.2x
Mon, 01 May 2023US$6.0tUS$2.5tUS$118.4b24.7x50.4x2.4x
Wed, 29 Mar 2023US$5.7tUS$2.5tUS$123.6b23.7x45.8x2.3x
Fri, 24 Feb 2023US$5.8tUS$2.5tUS$123.3b24.3x47.2x2.4x
Sun, 22 Jan 2023US$6.0tUS$2.5tUS$135.9b23.3x44.2x2.4x
Tue, 20 Dec 2022US$5.9tUS$2.5tUS$135.7b22.9x43.8x2.4x
Thu, 17 Nov 2022US$5.9tUS$2.4tUS$134.4b23.2x43.8x2.4x
Sat, 15 Oct 2022US$5.5tUS$2.4tUS$155.7b21.3x35.6x2.3x
Mon, 12 Sep 2022US$5.9tUS$2.4tUS$156.2b22.8x37.9x2.5x
Wed, 10 Aug 2022US$6.0tUS$2.4tUS$159.2b24.4x37.7x2.5x
Fri, 08 Jul 2022US$6.0tUS$2.6tUS$165.3b24.5x36x2.3x
Sun, 05 Jun 2022US$5.8tUS$2.6tUS$166.7b24.8x35x2.2x
Tue, 03 May 2022US$5.9tUS$2.5tUS$157.7b27.7x37.4x2.4x
Thu, 31 Mar 2022US$6.6tUS$2.5tUS$171.3b28.9x38.3x2.7x
Sat, 26 Feb 2022US$6.1tUS$2.5tUS$167.0b29.7x36.5x2.5x
Price to Earnings Ratio

36.5x


Total Market Cap: US$6.1tTotal Earnings: US$167.0bTotal Revenue: US$2.5tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 61.9x202320242025
Current Industry PE
  • Investors are optimistic on the American Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 70.8x which is higher than its 3-year average PE of 61.9x.
  • The industry is trading close to its 3-year average PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 21% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market1.21%
Healthcare-0.65%
Biotech3.75%
Healthtech1.66%
Medical Equipment-0.34%
Pharma-1.45%
Healthcare Services-1.82%
Life Sciences-2.98%
Industry PE
  • Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 58.8x.
    • Analysts are expecting annual earnings growth of 16.0%, which is higher than its past year's earnings decline of 0.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 32% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CVS CVS HealthUS$65.5719.2%
+US$13.5b		-14.1%PE17.9x
GILD Gilead SciencesUS$105.259.5%
+US$11.4b		46.1%PE273.3x
ABBV AbbVieUS$196.252.3%
+US$7.5b		11.7%PE81.7x
ISRG Intuitive SurgicalUS$600.891.6%
+US$3.3b		59.1%PE92.3x
HIMS Hims & Hers HealthUS$58.5034.2%
+US$3.3b		508.7%PE126.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MDT

US$86.07

Medtronic

7D

-5.6%

1Y

0.3%

Weekly Picks: SOUN's moat, FVRR's big bets and MDT's advantage

Feb 19
Weekly Picks: SOUN's moat, FVRR's big bets and MDT's advantage

HIMS

US$58.50

Hims & Hers Health

7D

34.2%

1Y

508.7%

Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)

Feb 19

CVS

US$65.57

CVS Health

7D

19.2%

1Y

-14.1%

GILD

US$105.25

Gilead Sciences

7D

9.5%

1Y

46.1%

Gilead Sciences' (NASDAQ:GILD) Upcoming Dividend Will Be Larger Than Last Year's

Feb 18
Gilead Sciences' (NASDAQ:GILD) Upcoming Dividend Will Be Larger Than Last Year's

MRK

US$83.29

Merck

7D

-3.8%

1Y

-34.6%

UNH

US$500.73

UnitedHealth Group

7D

-6.2%

1Y

-3.9%

UnitedHealth Group: Buy The Dip

Feb 17

ABBV

US$196.25

AbbVie

7D

2.3%

1Y

11.7%

WST

US$211.00

West Pharmaceutical Services

7D

-34.6%

1Y

-39.7%

West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities

Feb 17

ZTS

US$156.48

Zoetis

7D

-10.2%

1Y

-16.1%

Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year

Feb 15
Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year

GEHC

US$92.67

GE HealthCare Technologies

7D

6.5%

1Y

7.3%

GE HealthCare Technologies Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 15
GE HealthCare Technologies Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

ASND

US$156.19

Ascendis Pharma

7D

30.7%

1Y

-0.4%

Ascendis Pharma A/S (NASDAQ:ASND) Yearly Results: Here's What Analysts Are Forecasting For This Year

Feb 15
Ascendis Pharma A/S (NASDAQ:ASND) Yearly Results: Here's What Analysts Are Forecasting For This Year

EW

US$75.67

Edwards Lifesciences

7D

6.7%

1Y

-12.9%

ISRG

US$600.89

Intuitive Surgical

7D

1.6%

1Y

59.1%

TMO

US$523.09

Thermo Fisher Scientific

7D

-4.1%

1Y

-4.6%

LLY

US$857.20

Eli Lilly

7D

-0.9%

1Y

13.4%

HCA

US$316.71

HCA Healthcare

7D

-2.2%

1Y

2.6%

Many Still Looking Away From HCA Healthcare, Inc. (NYSE:HCA)

Feb 11
Many Still Looking Away From HCA Healthcare, Inc. (NYSE:HCA)